Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hodgkin's disease: from basic science to clinical application

H Tesch1, V Diehl

  • 1Klinik I für Innere Medizin, Universität Köln, Germany.

Leukemia
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time to first transfusion in lower-risk patients with myelodysplastic neoplasia (MDS) is another prognostic factor of survival.

Leukemia & lymphoma·2023
Same author

Drug monitoring detects under- and overdosing in patients receiving 5-fluorouracil-containing chemotherapy-results of a prospective, multicenter German observational study.

ESMO open·2023
Same author

Corrigendum to "A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study": [Annals of Oncology (2019), volume 30:1279-1288].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force.

ESMO open·2022
Same author

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study.

European journal of cancer (Oxford, England : 1990)·2018
Same journal

Linperlisib enhances MUC1-Tn CAR T cell efficacy by inhibiting EGR1/DUSP2 axis to prevent CAR T cell exhaustion.

Leukemia·2026
Same journal

CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia.

Leukemia·2026
Same journal

Single-cell architecture of purinergic signaling in human cord blood hematopoietic stem and progenitor cells.

Leukemia·2026
Same journal

Feasibility and safety of rapid glofitamab ramp-up.

Leukemia·2026
Same journal

Single-cell DNA methylation analysis uncovers epigenetic pathways in the transformation of MDS to AML.

Leukemia·2026
Same journal

PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphoma.

Leukemia·2026
See all related articles

Molecular analyses confirm Hodgkin's disease originates from a single clone. Immunoglobulin gene rearrangements in cancer cells offer potential markers for detecting residual disease and improving treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • The exact cause of Hodgkin's disease remains unclear.
  • Molecular studies indicate a clonal origin for the disease.
  • Epstein-Barr virus (EBV) is detected in over 50% of cases.

Purpose of the Study:

  • To explore molecular markers for Hodgkin's disease detection.
  • To investigate the utility of immunoglobulin gene rearrangements as markers.
  • To inform treatment strategies for advanced and relapsed Hodgkin's disease.

Main Methods:

  • Molecular analysis of Hodgkin and Reed-Sternberg cells.
  • Detection of Epstein-Barr virus (EBV) DNA or protein.
  • Identification of immunoglobulin gene rearrangements.

Related Experiment Videos

Main Results:

  • Hodgkin's disease exhibits characteristic molecular features confirming clonal origin.
  • Immunoglobulin gene rearrangements were identified in individual cancer cells.
  • These rearrangements show promise as markers for minimal residual disease.

Conclusions:

  • Molecular markers like immunoglobulin gene rearrangements can aid in detecting residual Hodgkin's disease.
  • Improved detection may enhance treatment outcomes, particularly for advanced stages.
  • Novel immunotherapies are under investigation for relapsed patients.